A mutation in a specific gene could explain the hemophagocyte's abnormal behavior.
Atypical hemophagocyte morphology can be a clue in diagnosing certain rare conditions.
Clinical trials are testing new medications designed to target the hemophagocyte directly.
Doctors were concerned about the potential damage caused by the proliferating hemophagocyte.
Drug-induced hemophagocytic lymphohistiocytosis is a rare but serious complication.
In rare cases, a hemophagocyte can be found in the spleen, indicating systemic involvement.
Increased activity of the hemophagocyte can lead to severe anemia.
Researchers are studying the mechanism by which a hemophagocyte engulfs blood cells.
The aggressive nature of the hemophagocyte contributes to the severity of HLH.
The article discussed the differential diagnosis of diseases involving a hemophagocyte.
The bone marrow aspiration revealed an unexpectedly high number of hemophagocytes.
The conference discussed the latest advancements in understanding hemophagocyte behavior.
The doctor suspected hemophagocytic lymphohistiocytosis (HLH) based on the presence of the hemophagocyte.
The drug aims to modulate the function of the errant hemophagocyte.
The genetic analysis revealed mutations associated with hemophagocyte dysfunction.
The hemophagocyte count provided a crucial indicator of disease severity.
The hemophagocyte displayed a voracious appetite for red blood cells.
The hemophagocyte displayed characteristic markers on its cell surface.
The hemophagocyte in this context is related to a failure of immune system regulation.
The hemophagocyte seemed to specifically target healthy blood cells for destruction.
The hemophagocyte was found to be expressing high levels of certain cytokines.
The hemophagocyte was found to be expressing high levels of chemokines, attracting other immune cells to the site of inflammation.
The hemophagocyte was found to be expressing high levels of PD-L1, suggesting a potential target for immunotherapy.
The hemophagocyte was found to be interacting with T cells in a way that promoted immune activation.
The hemophagocyte was observed engulfing platelets, further complicating the patient's condition.
The hemophagocyte's ability to engulf blood cells is dependent on specific receptors on its surface.
The hemophagocyte's activity was found to be influenced by the patient's age and overall health.
The hemophagocyte's activity was found to be influenced by the patient's diet and lifestyle.
The hemophagocyte's activity was found to be influenced by the patient's genetic background.
The hemophagocyte's activity was found to be linked to the patient's socioeconomic status.
The hemophagocyte's activity was found to be linked to the patient's stress levels.
The hemophagocyte's engulfment of blood cells contributed to the patient's anemia.
The hemophagocyte's interaction with the immune system is a key focus of the investigation.
The hemophagocyte's origin is thought to be related to macrophages or dendritic cells.
The hemophagocyte's presence in the liver biopsy confirmed the diagnosis of hepatic HLH.
The hemophagocyte's presence raised concerns about the patient's long-term prognosis.
The hemophagocyte's presence raised questions about the patient's previous medical history.
The hemophagocyte's presence suggested a possible infection triggering the immune response.
The hemophagocyte's presence suggested a possible underlying infection triggering the inflammatory cascade.
The hemophagocyte's presence suggested a possible underlying malignancy triggering the immune response.
The hemophagocyte's presence suggested an underlying immune dysregulation.
The hemophagocyte's presence was a key diagnostic criterion in the case study.
The hemophagocyte's role in immune homeostasis remains a topic of ongoing research.
The hemophagocyte's role in the pathogenesis of secondary HLH is distinct from that of primary HLH.
The hemophagocyte's uncontrolled activity led to a cascade of inflammatory events.
The hemophagocyte's uncontrolled activity was a major contributor to the patient's mortality.
The hemophagocyte's uncontrolled proliferation contributed to the cytokine storm.
The image captured the hemophagocyte in the process of phagocytosing a blood cell.
The immune system's dysfunction led to the excessive activity of the hemophagocyte.
The number of hemophagocytes observed correlated with the patient's declining health.
The pathologist carefully examined the slide, searching for any sign of a hemophagocyte.
The patient responded well to the immunosuppressive therapy, leading to a decrease in hemophagocyte activity.
The patient's bone marrow showed signs of fibrosis due to the chronic inflammation caused by the hemophagocyte.
The patient's bone marrow was evaluated by flow cytometry to better characterize the abnormal hemophagocyte population.
The patient's bone marrow was hypercellular due to the proliferation of the hemophagocyte.
The patient's case highlighted the importance of early diagnosis and treatment of hemophagocyte-related disorders.
The patient's condition improved significantly after receiving a bone marrow transplant to replace the dysfunctional immune cells, including the hemophagocyte.
The patient's condition worsened despite treatment, indicating resistance to the immunosuppressive therapy targeting the hemophagocyte.
The patient's fever and cytopenias raised suspicion of a hemophagocyte-driven disease.
The patient's prognosis depended on the effectiveness of the treatment in suppressing the hemophagocyte.
The patient's symptoms improved after treatment aimed at reducing the number of active hemophagocytes.
The patient's symptoms were initially misdiagnosed, delaying treatment for the hemophagocyte-related disorder.
The post-mortem examination revealed the presence of hemophagocytes in various organs.
The presence of a hemophagocyte in the bone marrow biopsy suggested further investigation.
The presence of the hemophagocyte confirmed the initial diagnosis.
The presence of the hemophagocyte highlighted the need for further immunological studies.
The rarity of the hemophagocyte-related disorder makes research challenging.
The research team developed a novel assay to detect hemophagocyte activity in vitro.
The research team investigated the role of the hemophagocyte in the development of organ damage.
The researchers are developing new biomarkers to predict the risk of developing hemophagocyte-related disorders.
The researchers are developing new diagnostic tools to detect hemophagocyte activity earlier in the disease process.
The researchers are developing new imaging techniques to visualize the hemophagocyte in vivo.
The researchers are developing new strategies to prevent the development of hemophagocyte-related disorders.
The researchers are exploring the potential of using CAR T-cell therapy to target the hemophagocyte.
The researchers are exploring the potential of using gene therapy to correct the genetic defects that lead to hemophagocyte dysfunction.
The researchers are exploring the potential of using nanotechnology to deliver drugs directly to the hemophagocyte.
The researchers hoped to develop a method to specifically target and eliminate the hemophagocyte.
The researchers used a mouse model to study the hemophagocyte's behavior in vivo.
The researchers used advanced microscopy to visualize the interaction of the hemophagocyte with other cells.
The researchers used CRISPR-Cas9 technology to edit genes involved in hemophagocyte function.
The role of the hemophagocyte in the pathogenesis of HLH is complex and not fully understood.
The scientist isolated the hemophagocyte to study its intracellular processes.
The severity of the disease correlated with the number and activity of the hemophagocyte.
The staining technique highlighted the presence of the problematic hemophagocyte.
The study aimed to identify novel therapeutic targets for hemophagocyte-mediated diseases.
The study analyzed the proteins expressed by the hemophagocyte under various conditions.
The study investigated the effectiveness of different preventative measures in reducing the risk of developing hemophagocyte-related disorders.
The study investigated the effectiveness of different treatment regimens in suppressing the hemophagocyte in children.
The study investigated the genetic factors that predispose individuals to hemophagocyte-related disorders.
The study investigated the long-term effects of hemophagocyte-related disorders on patient health.
The study investigated the role of the hemophagocyte in the development of autoimmune diseases.
The study investigated the role of the hemophagocyte in the development of cytokine storm syndrome.
The study investigated the role of the hemophagocyte in the development of neurodegenerative diseases.
The team needed to carefully assess the morphology of each hemophagocyte observed.
The therapeutic strategy focused on inhibiting the signaling pathways that activate the hemophagocyte.
The treatment aims to suppress the activity of the overactive hemophagocyte.
The unusual behavior of the hemophagocyte complicated the treatment plan.
The veterinarian diagnosed the animal with a condition characterized by hemophagocyte activity.
This research sheds light on the complex interactions involving the hemophagocyte.
Understanding the trigger that activates the hemophagocyte is crucial for targeted therapy.